Tumor microenvironment (TME)-responsive chemodynamic
therapy (CDT)
mediated by nanozymes has been extensively studied in oral squamous
cell carcinoma. However, the low catalytic efficiency due to insufficient
H2O2 in the TME is still a major challenge for
its clinical translation. Herein, we present an antitumor nanoplatform
based on a Mn–Co organometallic framework material (MnCoMOF),
which shows peroxidase-like (POD-like) activity, loaded with glucose
oxidase (GOx@MnCoMOF), demonstrating the ability of H2O2 self-supply and H2O2 conversion to
toxic hydroxyl radicals. The encapsulated GOx efficiently catalyzes
glucose into gluconic acid and H2O2 at the tumor
site, which can cut off the energy supply to inhibit tumor growth
and produce a large amount of H2O2 and acid
to compensate for their lack in the tumor microenvironment. The POD-like
activity of MnCoMOF can convert H2O2 into hydroxyl
radicals and eliminate tumor cells. The nanoplatform exhibits enhanced
tumor cell cytotoxicity in a high-glucose medium compared with a low-glucose
medium, illustrating sufficient generation of H2O2 from glucose by GOx. The in vivo results indicate
that GOx@MnCoMOF has excellent antitumor efficacy and can remodel
the immune-suppressive tumor microenvironment. In conclusion, the
GOx@MnCoMOF nanoplatform possesses dual enzymatic activities, i.e., POD-like and glucose oxidase, to achieve improved
tumor-suppressive efficiency through synergistic starvation and chemodynamic
therapy, thus providing a new strategy for the clinical treatment
of oral cancer.